Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
Publication year
2013Source
International Journal of Molecular Sciences, 14, 6, (2013), pp. 11347-11355ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Urology
Radiology
Journal title
International Journal of Molecular Sciences
Volume
vol. 14
Issue
iss. 6
Page start
p. 11347
Page end
p. 11355
Subject
NCEBP 14: Cardiovascular diseases; NCMLS 4: Energy and redox metabolism ONCOL 5: Aetiology, screening and detection; ONCOL 3: Translational research; ONCOL 3: Translational research NCMLS 6: Genetics and epigenetic pathways of disease; ONCOL 5: Aetiology, screening and detection; NCEBP 14: Cardiovascular diseases ONCOL 5: Aetiology, screening and detectionAbstract
PCA3 (prostate cancer gene 3) and multiparametric 3 tesla MRI are new promising diagnostic tools in the detection of PCa. Our aim was to study the clinical value of the Progensa PCA3-test: its predictive value for biopsy outcome, Gleason score and MRI outcome. We evaluated, retrospectively, 591 patients who underwent a Progensa PCA3-test at the Radboud University Nijmegen Medical Centre between May 2006 and December 2009. Prostate biopsies were performed in 290 patients; a multiparametric 3 tesla MRI of the prostate was performed in 163/591 patients. The PCA3-score was correlated to biopsy results and MRI outcome. The results show that PCA3 was highly predictive for biopsy outcome (p < 0.001); there was no correlation with the Gleason score upon biopsy (p = 0.194). The PCA3-score of patients with a suspicious region for PCa on MRI was significantly higher (p < 0.001) than in patients with no suspicious region on MRI (52 vs. 21). In conclusion, PCA3 is a valuable diagnostic biomarker for PCa; it did not correlate with the Gleason score. Furthermore, multiparametric MRI outcome was significantly correlated with the PCA3-score. Thus, PCA3 could be used to select patients that require MRI. However, in patients with a negative PCA3 and high clinical suspicion of PCa, a multiparametric MRI should also be done.
This item appears in the following Collection(s)
- Academic publications [238441]
- Electronic publications [122513]
- Faculty of Medical Sciences [90373]
- Open Access publications [97509]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.